Vasicinone
CAS No. 486-64-6
Vasicinone ( —— )
Catalog No. M24440 CAS No. 486-64-6
Vasicinone may act as a hepatoprotective agent. (±)-Vasicinone has significant antitussive, expectorant, and bronchodilating activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 290 | In Stock |
|
10MG | 430 | In Stock |
|
25MG | 695 | In Stock |
|
50MG | 945 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVasicinone
-
NoteResearch use only, not for human use.
-
Brief DescriptionVasicinone may act as a hepatoprotective agent. (±)-Vasicinone has significant antitussive, expectorant, and bronchodilating activities.
-
DescriptionVasicinone may act as a hepatoprotective agent. (±)-Vasicinone has significant antitussive, expectorant, and bronchodilating activities, which can be used to treat respiratory disease.(S)-Vasicinone exhibits antiproliferative activity against human gastric cancer cells MCG-803.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number486-64-6
-
Formula Weight202.2
-
Molecular FormulaC11H10N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1CN2C(=NC3=CC=CC=C3C2=O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antitussive, expectorant, and bronchodilating effects of quinazoline alkaloids (±)-vasicine, deoxyvasicine, and (±)-vasicinone from aerial parts of Peganum harmala L. Phytomedicine. 2015 Nov 15;22(12):1088-95.
molnova catalog
related products
-
Boc-NH-PEG6-CH2COOH
Boc-NH-PEG6-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
N-ε-propargyloxycarb...
N-ε-propargyloxycarbonyl-L-lysine hydrochloride is a modified amino acid for cancer therapy development.
-
DCB
DCB is an allosteric ligand for mGluR5 and shows the negative modulatory effect of 3,3′-dimethoxybenzaldazine (DMeOB).